Bone metastasis can be treated with targeted drugs such as zoledronic acid, ibandronate sodium, desuzumab, anastrozole or letrozole. Because bone metastasis belongs to the advanced stage of cancer, it is recommended that patients seek medical treatment in time for professional treatment.
1. Zoledronic acid
Zoledronic acid is suitable for the treatment of osteoporosis in postmenopausal women. The medicine can inhibit osteoclast activity, reduce bone resorption, and thus increase bone density. Pay attention to monitoring renal function when using, and avoid using it with other nephrotoxic drugs.
2. ibandronate sodium
Ibandronate sodium can be used to treat osteolytic bone metastasis caused by hypercalcemia and malignant tumor. It plays a role by reducing plasma calcium concentration, inhibiting osteoclast activity and osteolysis. Before use, patients should be evaluated for hypocalcemia risk, and the changes of hematological parameters should be closely monitored.
3. Disuzumab
Disuzumab is suitable for the treatment of osteolysis caused by unresectable or metastatic solid tumors. This drug can block the interaction between RANKL and RANK receptor, thus inhibiting osteoclast activity. Adverse reactions such as fatigue and headache may occur after injection, which can usually be relieved by themselves.
4. Anastrozole
Anastrozole is suitable for endocrine therapy in postmenopausal women with estrogen receptor positive breast cancer. This product is the third generation aromatase inhibitor, which can effectively inhibit the synthesis of estrogen in vivo and achieve therapeutic effect. It is suggested to check liver function regularly to find possible liver side effects in time.
5. Letrozole
Letrozole is also suitable for endocrine therapy of postmenopausal women with estrogen receptor positive breast cancer. This product is the second generation aromatase inhibitor, which has highly selective aromatase inhibition, thus reducing estrogen level. For patients with cardiovascular diseases, special attention should be paid to the changes of blood pressure during taking.
All the drugs mentioned above need to be used under the guidance of professional doctors to ensure safe and effective management of the disease. For bone metastasis, in addition to the above targeted drugs, bisphosphonates such as clodronate disodium can also be used as prescribed, which is beneficial to inhibit osteoclast activity and delay the process of bone destruction.